×

BMY – bristol-myers squibb co (US:NYSE)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day BMY SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
Access the BMY Earnings page here
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Top News Decliners
2/5 Bristol-Myers says a key trial for its lung cancer drug succeeds [CNBC] -8.5%
4/16 Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of Progression or Death by 42% Versus Chemotherapy in First-Line Lung Cancer Patients with High Tumor Mutational Burden (TMB) -8.3%
10/19 FDA extends action date to May 2019 for Bristol-Myers Squibb's Opdivo + Yervoy in 1st line lung cancer [Seeking Alpha] -6.7%
10/11 Bristol-Myers Squibb and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen in Advanced Solid Tumors -5.1%
1/16 Bristol-Myers Squibb Co (NYSE: BMY) was downgraded by analysts at Vetr Inc. from a "hold" rating to a "sell" rating. They now have a $60.72 price target on the stock. -4.5%
7/26 Bristol-Myers Squibb Reports Second Quarter Financial Results -3.9%
4/17 Bristol-Myers Squibb (NYSE: BMY) had its "outperform" rating re-affirmed by analysts at William Blair. -3.7%
6/1 U.S. Food and Drug Administration Lifts Partial Clinical Hold on Opdivo (nivolumab)-based Combination Study in Multiple Myeloma -3.4%
4/1 FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Bristol-Myers Squibb Company to Contact the Firm -3.3%
11/26 Bristol-Myers Squibb Announces CheckMate -451 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo Plus Yervoy Vs. Placebo as A Maintenance Therapy in Patients with Extensive-Stage Small Cell Lung Cancer After Completion of First-Line Chemo -3.0%

Don’t Miss Out On The Next BIG Stock Move

Don’t Miss Out On The Next BIG Stock Move

"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below:

Live Event: Join our next subscriber-only event: CPR Strategy

Register for our next upcoming LIVE training session, which will be hosted on Tuesday August 14th at 12:00 AM ET
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Live Event: Join our next subscriber-only event: "Bootcamp (Trading Plan)"

Register for our next upcoming LIVE training session, which will be hosted on Wednesday August 15th at 12:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Live Event: Join our next subscriber-only event: CPR Strategy

Register for our next upcoming LIVE training session, which will be hosted on Tuesday August 14th at 12:00 AM ET
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Live Event: Join our next subscriber-only event: Bootcamp (Trading Plan)

Register for our next upcoming LIVE training session, which will be hosted on Wednesday August 15th at 12:00 AM ET
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com